Mark Durand named to Watson senior vice president and CFO Millenium takes a long-term view on expansion Forteo performs admirably in study vs. Fosamax FDA approves Wyeth's Protonix for adults who can't take pills FDA proposes rules for conflict of interest disclosure for committee members Pfizer adds to its portfolio with Coley acquisition Ranbaxy recalls 73 million gabapentin tablets Noven appoints Michael Price vice president and CFO FDA grants priority review of drug for bipolar pre-teens MedImmune joins with others on $49.3 million investment into Ambit First Previous 2628 2629 2630 2631 2632 Next Last